Examining how executive function affects physical performance in obese individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between executive function problems and physical performance as well as overall well-being in individuals with obesity. Participants will be categorized into two groups based on their cognitive assessment scores and body mass index (BMI). The study will include individuals aged 18 to 65 with a BMI of 30 or higher, assessing how cognitive abilities impact their physical capabilities and quality of life. The findings could provide insights into the cognitive aspects of obesity and inform future interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

For the study group;

* Individuals volunteering for the study with BMI ≥30 kg/m2
* Individuals between the ages of 18-65 who volunteer to work
* Individuals who scored 21 points and above in the cognitive assessment

For the control group;

* Individuals volunteering for the study with BMI ≥30 kg/m2
* Individuals between the ages of 18 and 65 who are willing to work
* Scoring less than 21 points on the cognitive assessment

Exclusion Criteria:

* Being at a mental level that cannot understand and answer the questions posed
* Having a diagnosed neurological disease
* Having had cancer within the last 2 years
* Having major organ dysfunction
* Having uncontrolled type 2 diabetes
* Loss of vision, hearing

Where it's running

• Kutahya Health Sciences University
  Kütahya, Central, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: İsmail Okur, Assist. Prof.
• Email: ismail.okur@ksbu.edu.tr
• Phone: +905552436726

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.